Follow your curiosity

What discovery has been shared with you?

Start with one fact. Explore it, go deeper, then follow whichever branch catches your imagination.

Choose subjects for a surprise

Exploring any topic

Begin your discovery

Your next discovery is one click away.

Choose one or more subjects above, or leave Any Topic selected and let curiosity decide.

Chemistry

Selective Quantification of Protein Biomarkers with Immunoassays

Quick fact

Immunoassays can detect and quantify protein biomarkers at concentrations as low as a few picograms per milliliter — equivalent to finding one drop of a substance in a swimming pool.

Why this is interesting

Imagine finding a single needle in a haystack—but the needle is a protein floating in a drop of blood. How can we tell it apart from millions of other proteins?

Read the full explanation

Understanding Selective Quantification of Protein Biomarkers with Immunoassays

Immunoassays are like highly specific 'molecular detectives' that identify and measure proteins based on a lock-and-key fit. Antibodies are Y-shaped proteins that bind to a specific target (antigen) with remarkable precision. In an immunoassay, you use these antibodies to 'capture' your protein of interest from a complex mixture. By attaching a label—such as an enzyme that produces a color change or a fluorescent molecule—you can generate a signal that correlates with the amount of protein present. The most common format is ELISA (Enzyme-Linked Immunosorbent Assay), where the protein is captured on a plate, detected with a labeled antibody, and quantified by measuring the intensity of a colored reaction. To get a number, you run a series of standards with known concentrations to create a calibration curve.

A deeper explanation

The power of immunoassays lies in the specificity of the antibody-antigen interaction. Each antibody has a unique variable region that forms a three-dimensional pocket complementary to an epitope on the target protein. This interaction is driven by weak forces (hydrogen bonds, ionic interactions, van der Waals forces), but when many are combined, the binding is extremely strong (high affinity). This allows the antibody to 'pick out' its target even when the protein is present in a complex biological matrix like serum or plasma. In a non-competitive immunometric assay (like a sandwich ELISA), the protein is bound by a capture antibody and then by a detection antibody, ensuring high selectivity. The detection antibody carries an enzyme that converts a colorless substrate into a colored product. The absorbance of this product is measured spectrophotometrically and related to the protein concentration using a standard curve. Because the antibody binds only to the target, the assay can selectively quantify the biomarker without interference from other proteins. This principle is fundamental to clinical diagnostics, where biomarkers like PSA (prostate-specific antigen) or troponin are measured to detect diseases.

Keep FACTREE close

Internet access is required. Updates arrive when you reopen or reload the app. You may need to sign in again in the installed app.